US Airways Is on a ...
Health Care: Drugs
Par Pharmaceutical Companies Inc. (PRX: NYSE)
$49.98 0.02 | 0.04%
09/28/12 - 04:00 PM ET
Growth Rates
Growth Rates data is not available for PRX.
Portfolios with PRX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 9
- Contributor8 Pharma Stocks to Watch
- Contributor10 Health Care Stocks With ...
- Contributor10 Pharma Stocks With Upside
- UserBlue Star
- UserDavid Maxwell Portfolio 1
- UserPART 6 JPMorgan 28th Annual...
- UserMillion Contrarian
- Userkern44 Portfolio 1
- UserSUPRATRADE-0303071618
Latest PRX Headlines from TheStreet
- Stocks Slide as Economic Worries Return 07.16.12 | 03:07 pm
- Citigroup, Qualcomm: Stocks to Watch 07.16.12 | 09:07 am
- Stock Futures Off as Retail Sales Disappoint 07.16.12 | 09:07 am
- Par Pharma CEO: Double-Digit Growth
05.01.12 | 05:05 am - Par Pharmaceutical Companies Stock Hits New 52-Week High (PRX) 04.27.12 | 10:04 am
- WCG, CL, SJM, PRX Hit 52-Week Highs 03.30.12 | 11:03 am
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 03.30.12 | 09:03 am
- Par Pharmaceutical Companies Reaches New 52-Week High (PRX) 02.01.12 | 02:02 pm
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- Par Pharmaceutical Companies Stock Hits New 52-Week High (PRX) 01.19.12 | 01:01 pm
Press Releases for PRX
- Par Announces Completion Of Acquisition By TPG - PR Newswire 09.28.12 | 11:09 am
- Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date - PR Newswire 08.27.12 | 08:08 am
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Par Pharmaceutical Companies, Inc. - Business Wire 08.15.12 | 05:08 pm
- Ryan & Maniskas, LLP Announces Investigation Of Par Pharmaceutical Companies Inc. - Business Wire 07.20.12 | 10:07 am
- Securities Lawyers At Goldfarb LLP Seeking More Money, Information For Stockholders Of Par Pharmaceutical Companies, Inc. - PR Newswire 07.19.12 | 11:07 am
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Par Pharmaceutical Companies Inc. In Connection With The Sale Of The Company To TPG - Business Wire 07.18.12 | 07:07 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Par Pharmaceuticals Companies, Inc. - Business Wire 07.18.12 | 07:07 pm
- Law Firm Brower Piven Announces Investigation In Connection With Par Pharmaceutical Companies, Inc. Buyout - Business Wire 07.18.12 | 10:07 am
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Par Pharmaceuticals Companies, Inc. - PR Newswire 07.17.12 | 06:07 pm
- The Lin Law Firm Investigates Potential Breaches Of Fiduciary Duties In Connection With Proposed Acquisition Of Par Pharmaceutical Companies Inc. - PR Newswire 07.17.12 | 03:07 pm
Partner Headlines for PRX
- Par Pharma's 'Go Shop' Period Ends - Analyst Blog - NASDAQ 08.29.12 | 06:08 pm
- Healthcare Biz Recap: CareFusion's Voluntary RECALL, Somaxon SETTLES Suit - Wall St. Cheat Sheet 07.18.12 | 09:07 am
- TPG to Acquire Par Pharma for $1.9B - Analyst Blog - Zacks 07.17.12 | 07:07 pm
- Company News for July 17, 2012 - Corporate Summary - Zacks 07.17.12 | 10:07 am
- TPG's Bid For Par Reflects More Difficult Generic Environment - Seeking Alpha 07.17.12 | 09:07 am
- Ford Issuing Escape RECALL and 4 Must-Notice Hot Morning Stocks - Wall St. Cheat Sheet 07.16.12 | 11:07 am
- Stocks Down In Mixed Volume; Rentech Nitrogen Jumps - Investor's Business Daily 07.16.12 | 10:07 am
- Morning Market Movers - Benzinga 07.16.12 | 09:07 am
- Rignet SIGNS 2 Year Extension and 4 Stocks Hitting 52-Week Highs - Wall St. Cheat Sheet 07.16.12 | 07:07 am
- Healthcare Biz Roundup: Keryx Jumps Without CAUSE, Teva Not A MONOPOLIST - Wall St. Cheat Sheet 07.04.12 | 08:07 am
